Using information generated by AI, researchers developed a novel anti-toxoplasmosis drug.
Researchers explore how diet, exercise, and social engagement can help stave off cognitive impairment and improve overall brain health.
The prevalence of brain changes associated with LATE, a form of dementia first identified in 2019, may be as high as 40% in older adults and 50% in those with Alzheimer's disease.
APOE proteins were enhanced in the brains of patients with dementia, even when they did not carry the Alzheimer's associated gene.
Study reveals eleven genetic variants spanning ten genes, including previously unknown variants in two known Alzheimer's risk genes.
Glucosamine is a major component of brain glycogen, a new study reports.
DP-ASL, a new neuroimaging technique may help researchers identify early blood-brain barrier dysfunction associated with SVD.
Both the ApoE genotype and the sex of the mouse impacted the manner in which the animals with spinal cord injury responded to hypoxia treatment. Females with the ApoE e4 gene had a negative response to intermittent hypoxia.
Specific patterns of frontal brainwaves during everyday memory tasks help researchers to predict a patient's risk for developing mild cognitive impairment within five years.
Study reveals new criteria that could differentiate between FTD and LATE.
MW189, a small molecule drug candidate, blocks abnormal inflammation in the brain which contributes to injury and disease induced neurological impairments.
Gentamicin and G418, two aminoglycoside antibiotics, were effective at correcting genetic mutations associated with a specific form of frontotemporal dementia. The findings are promising for the treatment of frontotemporal dementia.
